Form 8-K - Current report:
SEC Accession No. 0001213900-24-072649
Filing Date
2024-08-27
Accepted
2024-08-26 17:40:23
Documents
14
Period of Report
2024-08-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0212447-8k_augmedix.htm   iXBRL 8-K 33141
2 EIGHTH OMNIBUS AMENDMENT, ENTERED INTO ON AUGUST 23, 2024, BY AND AMONG AUGMEDIX ea021244701ex10-1_augmedix.htm EX-10.1 15898
  Complete submission text file 0001213900-24-072649.txt   228719

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE augx-20240823.xsd EX-101.SCH 3015
4 XBRL LABEL FILE augx-20240823_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE augx-20240823_pre.xml EX-101.PRE 22359
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0212447-8k_augmedix_htm.xml XML 3794
Mailing Address 111 SUTTER STREET, SUITE 1300 SAN FRANCISCO CA 94104
Business Address 111 SUTTER STREET, SUITE 1300 SAN FRANCISCO CA 94104 561-989-2208
Augmedix, Inc. (Filer) CIK: 0001769804 (see all company filings)

EIN.: 833299164 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40890 | Film No.: 241242611
SIC: 7389 Services-Business Services, NEC
(CF Office: 07 Trade & Services)